Company
OraLiva
OraLiva’s non-invasive brush biopsy delivers precise, AI-powered insights on oral cancer and dysplasia empowering dental providers to detect disease early and take action with confidence.
Also known as OraLiva, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- general dentists and DSOs
- Legal name
- OraLiva, Inc.
Claim, correct or request removal
Record updated 17 September 2026
About
OraLiva collects a simple brush-biopsy sample with AI-powered cytology to deliver clinically-validated accuracy right in the hands of dental providers. Sample collection takes just minutes, fits seamlessly into a routine exam, and provides dentists with clear, data-driven results that support faster clinical decisions.
Funding snapshot
- Total raised
- $2MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Seed, $2M2025-10-07
Funding rounds
- Seed
- $2M2025-10-07, Company stated
- Grant
- 2025-07-21
- Round, 2025
- $1.5M2025-02-14, SEC form D sold, 1 investor
Products
- Other
- OraLiva Brush Biopsy
Loading relationship preview